Clinical Trial Update: Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine [Phase 4]

View source ↗

Summary

A phase 4 trial evaluating revaccination with the Bacille Calmette-Guérin (BCG) vaccine in young children was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: Bandim Health Project | Conditions: Malaria | Phase 4 | Status: TERMINATED